Aclaris Therapeutics Inc. (ACRS)
NASDAQ: ACRS
· Real-Time Price · USD
1.27
0.01 (0.79%)
At close: May 23, 2025, 3:59 PM
1.27
0.00%
After-hours: May 23, 2025, 04:58 PM EDT
0.79% (1D)
| Bid | 1.2 |
| Market Cap | 137.52M |
| Revenue (ttm) | 17.78M |
| Net Income (ttm) | -130.21M |
| EPS (ttm) | -1.59 |
| PE Ratio (ttm) | -0.8 |
| Forward PE | -1.95 |
| Analyst | Buy |
| Ask | 1.35 |
| Volume | 360,905 |
| Avg. Volume (20D) | 880,261 |
| Open | 1.25 |
| Previous Close | 1.26 |
| Day's Range | 1.22 - 1.28 |
| 52-Week Range | 0.95 - 5.17 |
| Beta | 0.43 |
About ACRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-2.65%
Aclaris shares are trading higher after the compan...
Unlock content with
Pro Subscription
6 months ago
+46.18%
Aclaris Therapeutics shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $3 to $13. Also, BTIG upgraded the stock from Neutral to Buy and announced a price target of $8.
